Home » MEDTRONIC HEART STENT LAGS RIVAL IN KEY TRIAL
MEDTRONIC HEART STENT LAGS RIVAL IN KEY TRIAL
Medtronic recently said its drug-coated stent fell slightly behind a chief rival in one key measure during clinical trials, but overall performance was good and U.S. sales could begin in 2007.
Santa Rosa Press Democrat (http://www1.pressdemocrat.com/apps/pbcs.dll/article?AID=/20051018/NEWS/510180370/1036/BUSINESS)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May